| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Interest income: |
| Interest income on loans | 11.5 | 10.9 | 34.2 | 0.0 | 8.0 | 7.5 | 32.2 | 0.0 |
| Interest income on repurchase agreements | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| | 13.6 | 13.0 | 12.1 | 11.0 | 10.0 | 9.1 | 9.0 | 9.1 |
| Interest expense: |
| Interest on deposits | 5.2 | 4.0 | 2.7 | 1.4 | 0.8 | 0.8 | 0.9 | 0.9 |
| | 5.9 | 5.1 | 3.4 | 1.9 | 1.0 | 1.0 | 1.1 | 1.1 |
| Net interest income | 7.8 | 7.8 | 8.7 | 9.1 | 9.0 | 8.1 | 7.9 | 8.0 |
| Provision for loan losses | 0.5 | | | | 0.6 | -0.5 | -2.8 | |
| Net interest income after provision for loan losses | 7.2 | 7.8 | 8.7 | 9.1 | 8.4 | 8.5 | 10.7 | 8.0 |
| Deposit and loan fees | 0.3 | 0.2 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
| Other non-interest income | 2.5 | 1.7 | 2.6 | 1.8 | 2.8 | 2.2 | 1.6 | 2.7 |
| Total non-interest income | 2.8 | 1.9 | 2.9 | 2.0 | 3.1 | 2.5 | 1.9 | 3.0 |
| Non-interest expenses | 10.2 | 8.7 | 9.0 | 8.6 | 9.6 | 8.6 | 8.7 | 8.5 |
| Pre-tax income before non-recurring items | 0.3 | 1.2 | 2.1 | 2.7 | 2.2 | 2.6 | 2.0 | 2.9 |
| Non-recurring items | 0.5 | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.4 | 0.3 |
| Pre-tax income | -0.2 | 1.0 | 1.9 | 2.5 | 1.9 | 2.4 | 1.7 | 2.7 |
| Income taxes | -0.4 | -0.1 | 0.2 | 0.2 | 0.1 | -0.1 | 0.3 | 0.3 |
| Tax rate | 226.8% | | 10.5% | 9.3% | 6.8% | | 18.4% | 12.0% |
| Net income | 0.2 | 1.1 | 1.7 | 2.3 | 1.8 | 2.5 | 1.4 | 2.3 |
| Net margin | 2.4% | 10.9% | 16.9% | 20.2% | 15.6% | 23.0% | 11.7% | 20.5% |
| |
| Basic EPS | $0.07 | $0.30 | $0.49 | $0.67 | $0.52 | $0.74 | $0.43 | $0.71 |
| Diluted EPS | $0.07 | $0.30 | $0.49 | $0.67 | $0.52 | $0.74 | $0.40 | $0.67 |
| |
| Shares outstanding (basic) | 3.5 | 3.5 | 3.4 | 3.5 | 3.5 | 3.4 | 3.2 | 3.2 |
| Shares outstanding (diluted) | 3.5 | 3.5 | 3.4 | 3.5 | 3.5 | 3.4 | 3.4 | 3.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |